2000 Central Avenue
Suite 100
Boulder, CO 80301
United States
720 505 4755
https://ir.frtx.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 4
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Albert Nicholas Marchio II | CEO, CFO, Secretary & Chairman | 251.83k | N/A | 1952 |
Aron Aizenstat M.B.A., P.M.P. | Vice President of Corporate Development & Operations | N/A | N/A | N/A |
Mr. Aaron Fox-Collis CPA | VP of Finance & Chief Accounting Officer | N/A | N/A | N/A |
Ms. Sue Fattor | Head of Human Resource | N/A | N/A | N/A |
Dr. James S. McElvain Ph.D. | Interim Head of CMC Development | N/A | N/A | N/A |
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Fresh Tracks Therapeutics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.